Gold prices edge up amid Fed rate cut hopes; US-Russia talks awaited
Investing.com - BioRestorative Therapies reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
BioRestorative Therapies announced earnings per share of $-1.28 on revenue of $29.00K. Analysts polled by Investing.com EPS of $-0.49 on revenue of $0.00.
BioRestorative Therapies 's are down 35% and is trading at $2.81 , still down 60.53% from its 52 week high of $7.12 set on Wednesday, December 1, 2021.
BioRestorative Therapies follows other major Healthcare sector earnings this month
BioRestorative Therapies's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on Friday, October 28, 2022 with third quarter EPS of $3.66 on revenue of $14.81B, for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar